Study guide
Gastrointestinal CT: Enterography, Colonography & Acute Abdomen
NMTCB CT
Track your progress as you read
Finished sections get a check mark.
1 CT System Hardware & X-Ray Generation
X-Ray Tube Design and Focal Spots Tube Heat Loading, Bearings and Cooling Beam Filtration and Collimation Scanner Generations and Source/Detector Geometry Detector Technology & Data Acquisition Systems (DAS)
2 Gantry Mechanics & Ancillary Systems
Gantry Architecture, Clearance and Centering Slip Rings, Couch Motion and Load Safety Power Injector Hardware and Safety DICOM, Worklists and Image Archiving
3 Data Acquisition & Scanning Geometries
Axial vs. Helical Scanning & Pitch Mechanics Localizer/Scout Scans & Isocenter Alignment Beam Geometry, Slice Collimation & Data Sampling
4 Mathematical Reconstruction & Image Processing
Projection Data, Image Matrices and Voxel Sampling Filtered Back Projection and Reconstruction Kernels Iterative Reconstruction & AI-Powered Algorithms Hounsfield Unit Scale, Linear Attenuation & Windowing (WW/WL)
5 3D Visualization & Advanced Post-Processing
Multiplanar Reformation (MPR) & Curved Planar Reformation (CPR) Volume Rendering, Maximum/Minimum Intensity Projections & Virtual Endoscopy
6 Image Quality & Performance Metrics
Spatial Resolution, Modulation Transfer Function & Matrix Parameters MTF and Spatial-Resolution Testing Contrast Resolution, Quantum Noise & Temporal Resolution Interdependence of Image Quality Parameters & Radiation Dose
7 CT Artifacts Identification & Correction
Physics-Based Artifacts: Beam Hardening, Cupping & Partial Volume Averaging Equipment & Patient Artifacts: Ring, Motion, Metal & Windmill Effects
8 Quality Assurance & Routine Testing
Daily Quality Control: Water Calibration, Noise & Field Uniformity Periodic Quality Assurance: ACR Phantom Testing & Geometry Verification
9 Patient Communication, Screening & Preparation
Patient Identification, Clinical Screening & Pregnancy Protocols Informed Consent, Pre-Scan Fasting & Anxiety Management Patient Monitoring, Vital Signs Assessment & ECG Gating Setup
10 Infection Control & Medical Emergency Response
Infection Control, Aseptic Technique & Scanner Disinfection Medical Emergencies in the CT Suite: Vasovagal Reactions, Seizures & Code Protocols
11 Contrast Media Chemistry & Administration
Iodinated Contrast Properties: Osmolality, Viscosity & Molecular Structure Contrast Volume, Flow, Duration and Iodine Delivery Intravenous Access, Catheter Gauges & Power Injection Protocols Bolus Tracking, Test Bolus & Contrast Transit Dynamics
12 Non-Vascular Contrast & Adverse Reactions
Oral, Rectal and Enteral Contrast Intrathecal, Intra-articular and Cavitary Contrast Renal Impairment, CI-AKI Risk & Metformin Management Contrast Reactions: Categorization, Prophylaxis & Emergency Treatment
13 Neuroimaging & Head/Neck CT Protocols
Routine Brain and Trauma CT Technique Stroke, Hemorrhage and Targeted Skull-Base CT Facial Bones, Orbits & High-Resolution Temporal Bones Soft Tissue Neck & Paranasal Sinuses Protocols
14 Thoracic & Cardiovascular CT Protocols
Routine Chest CT: Pulmonary Parenchyma & Mediastinal Anatomy High-Resolution CT (HRCT) for Diffuse Interstitial Lung Disease Pulmonary Embolism & Cardiac CT Protocols
15 Abdominal & Pelvic CT Protocols
Multiphase Liver, Pancreas & Renal CT Protocols Gastrointestinal CT: Enterography, Colonography & Acute Abdomen Pelvic Cross-Sectional Anatomy & Gynecologic/Urologic Pathology
16 Musculoskeletal, Vascular & Interventional CT
Cervical, Thoracic and Lumbosacral Spine CT Extremity, Joint and Orthopedic Hardware CT CT Angiography (CTA): Carotid, Aortic & Peripheral Runoff Protocols CT-Guided Interventions: Biopsy, Abscess Drainage & Procedural Safety
17 Hybrid PET/CT and SPECT/CT Procedures
PET/CT Anatomy, Physiology and Attenuation Correction SPECT/CT Anatomy, Physiology and Attenuation Correction
18 Radiation Biology & Dose Descriptors
Radiation Physics, Cellular Interactions & Biological Risk Models Tissue Reactions, Stochastic Risk and Justification CTDI Measurement and Phantom References CTDI Weighting, Pitch and DLP Calculations Size-Specific Dose Estimates Effective-Dose Estimates and Diagnostic Reference Levels
19 Radiation Protection & Dose Optimization
Technical Dose Reduction: Tube Current Modulation & Pediatric ALARA Pediatric, Body-Habitus and Pregnancy Optimization Personnel Protection, Distance and Shielding Jurisdiction, Dose Limits and Personnel Monitoring
Gastrointestinal CT: Enterography, Colonography & Acute Abdomen
Key Takeaways Explain This Topic AI
Neutral enteral contrast supports bowel-wall enhancement assessment.
Appendiceal diameter alone does not diagnose appendicitis.
CT colonography requires suitable distension and complementary views.
Last updated: October 2026
Acquisition settings and contrast timings below are illustrative adult protocol examples. Select the authorized protocol for the indication, scanner, body size, access device, and clinical condition. Treatment decisions belong to the responsible clinical team.
CT Enterography (CTE) Protocols & Small Bowel Imaging
Evaluating the small bowel has historically challenged diagnostic imaging due to its extensive length (approx. 5 to 7 meters 5\text{ to }7\text{ meters} 5 to 7 meters ), overlapping loops, active peristalsis, and physiological collapse. Conventional positive oral contrast agents opacify the lumen with high radiodensity ( + 200 to + 400 HU +200\text{ to }+400\text{ HU} + 200 to + 400 HU ), which completely obscures mucosal enhancement, subtle mucosal ulcerations, low-attenuation wall edema, and intraluminal bleeding. CT Enterography (CTE) is a specialized technique optimized for visualizing small bowel mucosal and mural pathology, serving as the frontline cross-sectional modality for inflammatory bowel disease (Crohn's disease), obscure gastrointestinal bleeding (OGIB), and small bowel neoplasms (carcinoids, adenocarcinoma, lymphoma, and gastrointestinal stromal tumors [GISTs]).
Neutral Enteral Contrast Selection & Administration
Mechanism of Neutral Contrast: Neutral enteral contrast agents exhibit an attenuation profile equivalent to water, ranging between − 20 and + 20 HU -20\text{ and }+20\text{ HU} − 20 and + 20 HU . While plain water rapidly diffuses across the jejunal mucosa—resulting in collapsed, non-diagnostic distal loops—commercial CTE agents (such as VoLumen , a 0.1 % w/v 0.1\%\text{ w/v} 0.1% w/v dilute barium sulfate suspension) incorporate non-absorbable osmotic additives, specifically sorbitol and locust bean gum. Sorbitol exerts an intraluminal osmotic gradient that prevents mucosal water absorption, ensuring robust, uniform luminal distension from the duodenum to the terminal ileum.
Ingestion Schedule: Total volume of 1500 mL 1500\text{ mL} 1500 mL in this illustrative schedule, split into timed aliquots split into timed aliquots:
45 minutes 45\text{ minutes} 45 minutes prior to scan: Ingest first bottle ( 450 mL 450\text{ mL} 450 mL ).
30 minutes 30\text{ minutes} 30 minutes prior to scan: Ingest second bottle ( 450 mL 450\text{ mL} 450 mL ).
15 minutes 15\text{ minutes} 15 minutes prior to scan: Ingest third bottle ( 450 mL 450\text{ mL} 450 mL ).
Immediately before scanning: Ingest a final glass of water ( 150 mL 150\text{ mL} 150 mL ) on the scanner table to distend the stomach and proximal duodenum.
Intravenous Contrast & Enteric Phase Delay
Injection Parameters: High injection rate of 4.0 to 5.0 mL/s 4.0\text{ to }5.0\text{ mL/s} 4.0 to 5.0 mL/s of non-ionic iodinated contrast ( 100 to 125 mL 100\text{ to }125\text{ mL} 100 to 125 mL at 350 to 370 mg I/mL 350\text{ to }370\text{ mg I/mL} 350 to 370 mg I/mL ) to produce sharp arterial-capillary contrast bolus delivery.
Enteric Phase Timing ( 45 – 50 s 45\text{--}50\text{ s} 45 – 50 s Delay): Scanned at 45 to 50 seconds 45\text{ to }50\text{ seconds} 45 to 50 seconds post-injection (an intermediate phase between late arterial and portal venous phases). This timing precisely captures the peak mucosal enhancement of the small bowel wall while the neutral intraluminal fluid remains dark (water attenuation), producing maximum diagnostic contrast between the bright, hyperenhancing bowel mucosa and the dark lumen.
Imaging Biomarkers of Active Crohn's Disease on CTE
Mucosal Hyperenhancement: Intense iodine uptake in the inflamed small bowel mucosa compared to adjacent normal loops, reflecting acute capillary engorgement and neovascularity.
Mural Thickening ( > 3 mm >3\text{ mm} > 3 mm ): Normal distended small bowel wall measures ≤ 2 to 3 mm \le 2\text{ to }3\text{ mm} ≤ 2 to 3 mm . In active Crohn's, mural thickness typically reaches 5 to 10 mm 5\text{ to }10\text{ mm} 5 to 10 mm .
Mural Stratification ("Target" or "Double-Halo" Sign): Visualized on axial and coronal reformations as alternating concentric layers: an inner hyperenhancing mucosal ring, a middle hypoattenuating submucosal layer (representing inflammatory submucosal edema or chronic fat deposition), and an outer hyperenhancing muscularis propria/serosa.
The "Comb Sign": Marked engorgement, dilation, and tortuosity of the mesenteric vasa recta supplying the inflamed bowel loop. The parallel alignment of these hyperemic vessels mimics the teeth of a comb, serving as a reliable sign of active transmural inflammation.
Fibrofatty Proliferation ("Creeping Fat"): Hypertrophy of mesenteric adipose tissue along the mesenteric border of the diseased segment, causing wide separation of adjacent bowel loops.
Complicated Penetrating & Stenosing Disease: Identifies transmural sinus tracts, fistulas (enteroenteric, enterovesical, enterocutaneous), mesenteric inflammatory phlegmons, abscesses, and assesses inflammatory and fibrotic components of strictures, which can coexist. Imaging does not always separate them completely.
The Acute Abdomen on CT
Computed tomography has become the definitive diagnostic modality for acute, non-traumatic abdominal pain, rapidly diagnosing surgical emergencies and preventing unnecessary exploratory laparotomies.
Acute appendicitis, diverticulitis and obstruction
For appendicitis, identify the appendix from its cecal origin and assess caliber together with wall enhancement, periappendiceal fat changes, fluid and complications. Diameter above 6 mm alone is not diagnostic, since a normal appendix can exceed that value. An appendicolith may be present without acute inflammation. Coverage and reconstruction must allow the appendix to be traced, including a pelvic or retrocecal course.
Diverticulitis can produce localized bowel wall thickening and adjacent fat inflammation near diverticula. Look for abscess, extraluminal gas, obstruction or fistula. An abscess size does not automatically determine drainage in every patient; clinical stability, location and accessibility influence treatment. If a leak question is added, select enteral or rectal contrast through the responsible clinician's plan.
For obstruction, identify dilated proximal bowel, a transition and decompressed distal bowel, then assess causes and signs of compromised perfusion. Closed-loop configuration, mesenteric distortion, reduced wall enhancement or concerning fluid warrant prompt attention. Pneumatosis or portal venous gas can occur in different settings and is not universal proof of irreversible necrosis. Communicate potentially urgent findings instead of assigning viability from one sign.
A high-grade obstruction examination should not be unnecessarily delayed to force large oral volumes. IV enhancement can help assess bowel-wall perfusion when appropriate. The protocol must address the actual question and the patient's condition.
CT Colonography (CTC / Virtual Colonoscopy)
CT Colonography (virtual colonoscopy) provides a minimally invasive, high-resolution endoluminal and cross-sectional evaluation of the entire large intestine, serving as a primary screening tool for colorectal cancer and polyps, and as the gold standard alternative when optical colonoscopy is incomplete due to severe tortuosity, stricture, or dolichocolon.
Patient Preparation & Tagging Protocols
Cathartic Bowel Cleansing: Low-residue diet followed by osmotic laxatives (polyethylene glycol, magnesium citrate, or sodium picosulfate) to clear solid feces from the mucosal surface.
Fecal and Fluid Tagging:
Stool and fluid tagging: follow the approved agent concentrations, volumes and drinking schedule. Tagged material becomes conspicuous against untagged soft tissue. Distinguish tagged stool from a wall-attached polyp by multiple views and positions. Electronic cleansing can help but can also introduce artifacts; inspect source images.
Carbon Dioxide ( C O 2 CO_2 C O 2 ) Insufflation & Dual-Position Scanning
Automated Mechanical Insufflation: A thin, flexible balloon catheter is placed in the rectum, and carbon dioxide ( C O 2 CO_2 C O 2 ) is insufflated into the colon under automated pressure control (typically 15 to 25 mmHg 15\text{ to }25\text{ mmHg} 15 to 25 mmHg ) until complete distension is achieved ( 3 to 4 liters 3\text{ to }4\text{ liters} 3 to 4 liters total volume).
Why Carbon Dioxide Over Room Air? Carbon dioxide is absorbed across the colonic mucosa more rapidly than room air and is eliminated through pulmonary respiration. More rapid absorption can improve postprocedure comfort, but does not eliminate pain or other complications associated with manual room-air pumping.
Dual Positioning (Supine & Prone): Imaging must be acquired in both the supine and prone positions (or supine and lateral decubitus if the patient cannot lie prone). Positional shifts cause mobile residual fluid and tagged fecal pellets to tumble to the dependent wall, allowing the nondependent mucosal surfaces to be fully evaluated. A true polyp is fixed to the bowel wall and remains in the same anatomic position on both scans, whereas residual stool shifts to the dependent wall.
Current C-RADS categories
CT colonography evaluates the distended lumen in complementary views and positions. Distinguish a true polyp from tagged stool, fluid or a fold by attenuation, attachment and behavior across positions. The 2023 C-RADS update distinguishes C2a , including one or two 6–9 mm polyps, from C2b , a likely benign mass-like finding such as a diverticular stricture. C3 includes a polyp of at least 10 mm or at least three 6–9 mm polyps. Follow the complete reporting system and clinical pathway; these category descriptions do not authorize the technologist to prescribe follow-up independently.
Reference: ACR C-RADS 2023 changes .